{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-011110","form_type":"8-K","ticker":"DXR","cik":"0000027367","company_name":"DAXOR CORP","filed_at":"2024-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.513500+00:00","generated_at":"2026-06-04T08:49:27.628220+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Daxor acquires worldwide rights to Volumex, Megatope, and Glofil from Iso-Tex Diagnostics","bullets":["No upfront payment; seller-financed with monthly installments starting after manufacturing transition in 6–9 months.","Deal expected to be immediately accretive and cash flow positive due to higher margins from in-house production.","Glofil (GFR diagnostic) adds recurring revenue stream and cross-selling opportunity to existing hospital customers.","Volumex and Megatope radiopharmaceuticals for blood volume analysis will be produced at Daxor's Oak Ridge facility.","Transaction subject to customary closing conditions including applicable regulatory approvals."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-011110","json":"https://secwatch.observer/filing/0001493152-24-011110.json","markdown":"https://secwatch.observer/filing/0001493152-24-011110.md","text":"https://secwatch.observer/filing/0001493152-24-011110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/27367/000149315224011110/0001493152-24-011110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/27367/000149315224011110/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T08:49:27.628220+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}